Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 238.00
+1.00 (0.42%)
Oct 9, 2026, 4:59 PM CET
Zealand Pharma Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Zealand Pharma stock has a consensus rating of "Buy" and an average price target of kr 408.36. The average 1-year stock price forecast is 71.58% higher than the current stock price, while the lowest is kr 300.00 (+26.05%) and the highest is kr 595.00 (+150.00%).
Price Target: kr 408.36 (+71.58%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zealand Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 6 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 2 | 1 |
| Hold | 5 | 7 | 8 | 8 | 8 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 16 | 16 |
Financial Forecast
Revenue This Year
4.80B
from 9.21B
Decreased by -47.96%
Revenue Next Year
4.31B
from 4.80B
Decreased by -10.19%
EPS This Year
27.55
from 90.22
Decreased by -69.47%
EPS Next Year
7.45
from 27.55
Decreased by -72.94%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.